Cargando…
Patient Accessibility and Budget Impact of Orphan Drugs in South Korea: Long-Term and Real-World Data Analysis (2007–2019)
This study aimed to identify orphan drug accessibility and impact on pharmaceutical budgets in South Korea by analyzing the status of orphan drug designation, approval, reimbursement, and pharmaceutical expenditure. We analyzed the dataset on orphan drugs designated, approved, and reimbursed from 20...
Autores principales: | Lee, Se Hee, Yoo, Seung-Lai, Bang, Joon Seok, Lee, Jong Hyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246809/ https://www.ncbi.nlm.nih.gov/pubmed/32357397 http://dx.doi.org/10.3390/ijerph17092991 |
Ejemplares similares
-
Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison
por: Lee, Jong Hyuk
Publicado: (2021) -
Impact of orphan drugs on Latvian budget
por: Logviss, Konstantins, et al.
Publicado: (2016) -
Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System
por: Yoo, Seung-Lai, et al.
Publicado: (2019) -
Research on Korean Pharmacopuncture in South Korea since 2007
por: Lim, ChungSan, et al.
Publicado: (2014) -
2007 Budget - Scale of Contributions
Publicado: (2006)